Lucknow Speciality Pharma

Fam-trastuzumab Deruxtecan-nxki Injection 100 mg
Fam-trastuzumab deruxtecan-nxki injection is used to treat HER2-positive metastatic (cancer that has spread to other parts of the body) breast cancer or whose cancer cannot be removed with surgery in patients who have previously received two or more anti-HER2-based regimens in the metastatic setting. To get access, please contact Patient Support Team @ +91 9760014849 / 9555306364 / 9794360370 / 9140551027, Time 9 am - 8 pm IST or send us a request on email (urgent@lucknowpharma.com) / WhatsApp for the same.
Get Access Price
WhatsApp

Fam-trastuzumab Deruxtecan-nxki Injection was approved for medical use in the United States in 2019. It is on the World Health Organization’s List of Essential Medicines.

Fam-trastuzumab Deruxtecan-nxki Injection Available Price In Lucknow Banaras Nepal

Fam-trastuzumab Deruxtecan-nxki Injection

  • Packaging – Single Use Vial
  • Strength –  100 mg
  • Brand Name – Enhertu
  • API – Fam-trastuzumab Deruxtecan-nxki

What is Fam-trastuzumab Deruxtecan-nxki used for? 

Fam-trastuzumab deruxtecan-nxki injection is used to treat HER2-positive metastatic (cancer that has spread to other parts of the body) breast cancer or whose cancer cannot be removed with surgery in patients who have previously received two or more anti-HER2-based regimens in the metastatic setting.

Facts of Medicines

Fam-trastuzumab Deruxtecan-nxki Injection 100 mg

STORAGE AND HANDLING

This Injection must be refrigerated at 2°C to 8°C (36°F to 46°F). Do not use the Fam-trastuzumab Deruxtecan-nxki Injection beyond the expiration date located on the carton and the vial.

SIDE EFFECTS

The following clinically significant adverse reactions can occur with Fam-trastuzumab Deruxtecan-nxki Injection: Cardiovascular Toxicity, Myelosuppression, Hypersensitivity, Hypertension, Pancreatic Toxicity.

DOSAGE

• Do not substitute ENHERTU for or with trastuzumab or adotrastuzumab emtansine. 

• For intravenous infusion only. Do not administer as an intravenous push or bolus. Do not use Sodium Chloride Injection, USP.

• The recommended dosage of ENHERTU for breast cancer is 5.4 mg/kg given as an intravenous infusion once every 3 weeks  day cycle) until disease progression or unacceptable toxicity. 

• The recommended dosage of ENHERTU for gastric cancer is  6.4 mg/kg given as an intravenous infusion once every 3 weeks  day cycle) until disease progression or unacceptable toxicity. 

• Management of adverse reactions (ILD, neutropenia, thrombocytopenia, or left ventricular dysfunction) may require temporary interruption, dose reduction, or discontinuation of ENHERTU.
For injection: 100 mg lyophilized powder in a single-dose vial (3)

WARNINGS AND PRECAUTIONS

  • Genetic testing should be indicated in order to detect whether a person is at higher risk of developing hypersensitivity.
  • Fam-trastuzumab Deruxtecan-nxki Injection may not be added as a single agent when antiretroviral regimens are changed because of loss of the virologic response.
  • Patients with liver disease should be watchful and cautious in order to Fam-trastuzumab Deruxtecan-nxki Injection because it can aggravate the condition.
  • In patients with Fam-trastuzumab Deruxtecan-nxki Injection, conditions like immune reconstitution inflammatory syndrome, a change in body fat as well as an increased risk of heart attack may occur.
  • Fam-trastuzumab Deruxtecan-nxki Injection is not recommended for use in infants who are under 3 months of age.
  • Cases like lactic acidosis and severe hepatomegaly with steatosis occurred with the use of nucleoside analogues.
  • Sometimes serious hypersensitivity reactions have been associated with Fam-trastuzumab Deruxtecan-nxki Injection.

FAQs – Medicine Questions

Fam-trastuzumab Deruxtecan-nxki Injection 100 mg
What is FAM-trastuzumab Deruxtecan-NXKI?
Descriptions. Fam-trastuzumab deruxtecan-nxki injection is used to treat HER2-positive metastatic (cancer that has spread to other parts of the body) breast cancer or whose cancer cannot be removed with surgery in patients who have previously received two or more anti-HER2-based regimens in the metastatic setting.
Is FAM-trastuzumab Deruxtecan-NXKI chemotherapy?
Yes, Enhertu (Fam-trastuzumab deruxtecan-nxki) is a chemo drug (chemotherapy) and it is also a targeted therapy anti-cancer drug. Enhertu fights cancer in two ways: the antibody (trastuzumab) part is designed to find and attach to the HER2 receptor on cancer cells.
Where can I buy Fam-trastuzumab Deruxtecan-nxki Injection?

You can buy Fam-trastuzumab Deruxtecan-nxki Injection from any authorized whole-seller after getting a prescription from a qualified doctor. It is always better to check the credential of the whole-seller/supplier/exporter before buying the product.

The buyer should check the existing law in their home country before importing the product.

What is the procedure to buy Fam-trastuzumab Deruxtecan-nxki Injection?

Patients can simply fill the order form or can send mail at info@lucknowpharma.com  Patients can also send WhatsApp messages to +91-9555306364 We will reply ASAP with the details of the Fam-trastuzumab Deruxtecan-nxki Injection price as well as procurement procedure.

Note:- The order will be confirmed only after the receipt of the Valid prescription of the Clinician.

Is trastuzumab a deruxtecan?
Fam-trastuzumab deruxtecan contains a monoclonal antibody called trastuzumab that binds to a protein called HER2, which is found on some cancer cells. It also contains an anticancer drug called deruxtecan, which may help kill cancer cells. Fam-trastuzumab deruxtecan is a type of antibody-drug conjugate.

NEWS / UPDATES